WHO's emergency listing of Chinese vaccine to benefit global COVID-19 fight
GENEVA, May 9 (Xinhua) -- The World Health Organization (WHO) on Friday validated the COVID-19 vaccine developed by China's Sinopharm for emergency use, a move widely welcomed by officials and experts worldwide and set to benefit the global fight against the pandemic.
This is a "great success and benefit for the world" because the Sinopharm COVID-19 vaccine validated by the WHO is proving very effective in countries including Pakistan where it is being administered, said Musarrat Amin, a Pakistani strategic security analyst.